Varenicline and Cytisine Patient Group Directions (PGD) Spending Approval
August 12, 2025 Director of Public Health - Alice Wiseman (Officer) Approved View on council websiteFull council record
Purpose
The purpose of this report is to request
approval for the funds needed to participate in the Regional
Patient Group Directions (PGD) for Varenicline and Cytisine stop
smoking medications.
Content
The Director of Public Health
is recommended to:
Approve the spend and invoicing arrangements
as described in paragraph 5.
Supporting Documents
Details
| Outcome | Recommendations Approved |
| Decision date | 12 Aug 2025 |